Physician profile
Stephen Lobue
NPI 1245735984
$14,289.55
in general payments reported to CMS, 2019-2025
16 companies · $9,486 in 2025
The $9,486 reported for 2025 was more than what 95% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $259 · 2023: $1,591 · 2024: $2,954 · 2025: $9,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,800 · Food and Beverage: $5,815 · Travel and Lodging: $416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,800.00 |
| Food and Beverage | $5,814.72 |
| Travel and Lodging | $415.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $8,889.82 | 2023-2025 | Travoprost Intraocular Implant - Idose, Idose, Idosetr |
| Alcon Vision LLC | $1,816.65 | 2022-2025 | Clareon, Ngenuity, Hydrus Microstent |
| Rxsight INC | $1,522.86 | 2022-2025 | Rxsight Injector Handpiece, Rxsight Light Delivery Device (Ldd), Light Adjustable Lens (Lal) |
| Sight Sciences, INC. | $648.17 | 2022-2025 | Omni Surgical System, Sion Surgical Instrument |
| New World Medical,INC. | $332.35 | 2023 | |
| Bausch & Lomb Americas INC. | $241.77 | 2024-2025 | Envista Mx60 Iol, Miebo, Xiidra |
| Ocular Therapeutix, INC. | $166.96 | 2025 | Dextenza |
| Dompe US, INC. | $150.73 | 2023 | Oxervate |
| Harrow Eye, LLC | $144.13 | 2024 | Vevye |
| Oyster Point Pharma, INC. | $101.33 | 2022-2023 | Tyrvaya |
| Novartis Pharmaceuticals Corporation | $92.23 | 2023 | |
| Tarsus Pharmaceuticals, INC. | $74.67 | 2024 | Xdemvy |
| Mallinckrodt Hospital Products INC. | $36.41 | 2025 | Acthar |
| Abbvie INC. | $31.36 | 2023 | |
| Horizon Therapeutics Plc | $20.83 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $19.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Lobue listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.